A Bayesian Phase I/II Trial Design for Immunotherapy (Q4559685)

From MaRDI portal
scientific article; zbMATH DE number 6988477
Language Label Description Also known as
English
A Bayesian Phase I/II Trial Design for Immunotherapy
scientific article; zbMATH DE number 6988477

    Statements

    A Bayesian Phase I/II Trial Design for Immunotherapy (English)
    0 references
    0 references
    0 references
    0 references
    4 December 2018
    0 references
    0 references
    Bayesian adaptive design
    0 references
    dose finding
    0 references
    immune response
    0 references
    immunotherapy
    0 references
    phase I/II trial
    0 references
    risk-benefit tradeoff
    0 references
    0 references
    0 references